Family Council Joins Letter Urging President Trump to Restrict Abortion Drugs

Last week Family Council joined a letter with more than 50 other state and national pro-life leaders urging President Trump to place better safeguards on abortion drugs like the RU-486 regimen that uses mifepristone and misoprostol.

recent study by the experts at the Ethics and Public Policy Center shows RU-486 is at least 22 times more dangerous than U.S. Food and Drug Administration labeling indicates.

The study — which relied on all-payer insurance claims data from 2017 to 2023 — found nearly one in nine women experienced serious health complications from abortion drugs. Women who took the abortion drugs experienced sepsis, infection, hemorrhaging, and other life-threatening complications.

With such serious complications, it’s clear that abortion drugs simply should not be for sale in America. That is why Family Council joined the letter last Tuesday urging the president to consider stronger policies against RU-486.

The letter reads in part,

Many states have laws protecting against mifepristone not only because it kills an unborn child, but also because of the grave risk it poses to women.

The FDA label for mifepristone states fewer than 0.5 percent of women experience serious adverse reactions from mifepristone. However, data released April 28, 2025 examines 865,727 prescribed mifepristone abortions from 2017 to 2023 and demonstrates that 10.93 percent of women—22 times higher than the FDA reported 0.5 percent—experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion. The risk from mifepristone could jeopardize a mother’s life. . . .

States must be empowered to enforce pro-life laws, all the original safety protocols on mifepristone must be restored, and the FDA must investigate mifepristone, reconsidering its approval altogether. The lives of women and unborn children and the rights of states depend upon it.

Over the years, Arkansas’ state legislators have enacted excellent laws prohibiting abortion and preventing abortion drugs from being delivered by mail in Arkansas. But the FDA and the federal government have taken steps that threaten to undermine these good, pro-life laws, and pro-abortion states are protecting abortionists who mail abortion drugs into Arkansas.

Abortion drugs don’t just kill unborn children. They also harm women. That’s simply one more reason why our country needs to protect everyone from these dangerous drugs.

Articles appearing on this website are written with the aid of Family Council’s researchers and writers.

Abortion Pill 22 Times More Dangerous Than FDA Claims: New Study

A new study shows the RU-486 abortion pill regimen is at least 22 times more dangerous than U.S. Food and Drug Administration labeling indicates.

The study raises serious concerns about the harm that abortion drugs cause.

Researchers from the Ethics and Public Policy Center reviewed insurance claim data from 865,727 RU-486 prescriptions as part of the “largest-known study” on abortion pill complications.

Their data found that from 2017 to 2023, nearly 11% of women who used abortion drugs experienced sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion. That is significantly higher than the FDA’s figure claiming “less than 0.5 percent” experienced complications in clinical trials for the drug regimen.

The study concluded:

  • The FDA should immediately reinstate its earlier, stronger patient safety protocols to ensure physician responsibility for women who take mifepristone under their care, as well as mandate full reporting of its side effects.
  • The FDA should further investigate the harm mifepristone causes to women and, based on objective safety criteria, reconsider its approval altogether.

We have written repeatedly about the dangers of abortion drugs like RU-486.

Last year, Family Council joined a pro-life amicus brief by more than 30 other state and national groups as part of two lawsuits over the FDA’s decision to approve the abortion drug mifepristone, also known as RU-486, and to eliminate safety protocols and standards for the drug.

Among other things, the amicus brief noted:

  • The FDA also removed safety standards requiring a woman to be assessed in-person by a doctor before receiving RU-486.
  • The FDA knew about the significant negative health consequences of mifepristone — or RU-486 — before approving it in 2000.
  • Despite the danger, the FDA has removed safety requirements designed to protect women and weakened the reporting requirements for adverse events caused by RU-486.

Abortion-inducing drugs are dangerous. Official reports from the Arkansas Department of Health reveal that between 2020 and 2022 at least 1 in 50 women who took abortion drugs in Arkansas experienced complications.

Over the years, Arkansas’ state legislators have enacted various laws prohibiting abortion and preventing abortion drugs from being delivered by mail in Arkansas. But the FDA and the federal government have taken steps that threaten to undermine these good, pro-life laws.

This new data from the Ethics and Public Policy Center once again shows abortion drugs not only kill unborn children but also harm women. That’s simply one more reason why our state needs to protect people from these dangerous drugs.

Articles appearing on this website are written with the aid of Family Council’s researchers and writers.

Title IX Showdown: Feds Call Foul on UPenn

On Monday, the U.S. Department of Education issued a press release announcing the University of Pennsylvania violated Title IX by failing to prevent biological males from competing in women’s athletics and use women’s locker rooms at the school.

Earlier this year, President Trump signed an executive order to help protect women and girls from being forced to compete against men. It also protects women’s right to privacy in locker rooms, showers, changing areas, and similar facilities. It also directs federal officials to withdraw funding from educational programs that “deprive women and girls of fair athletic opportunities.”

The Department of Education’s letter indicates the University of Pennsylvania has 10 days to resolve the violation. If it is not resolved voluntarily, the issue will be referred to the U.S. Department of Justice.

We have written time and again about how women’s athletics is at risk of being erased in America.

Female cyclists, swimmerspowerlifterssprintersvolleyball players, and others have seen their sports radically changed by men who claim to be women.

In 2021 Arkansas passed Act 461 by Sen. Missy Irvin (R — Mountain View) and Rep. Sonia Barker (R — Smackover) to prevent male student athletes from competing against girls in women’s athletics at school. This good law protects fairness in women’s sports in Arkansas.

In 2023 Arkansas lawmakers passed Act 317 by Rep. Mary Bentley (R – Perryville) and Sen. Dan Sullivan (R – Jonesboro) to protect privacy in public school locker rooms, showers, restrooms, changing areas, and similar facilities by requiring public schools to designate these facilities for “male” or “female” use.

And this year legislators passed Act 955 by Sen. Blake Johnson (R — Corning) and Rep. Mary Bentley (R — Perryville) protecting physical privacy and safety of Arkansans in showers, locker rooms, changing rooms, restrooms, and sleeping quarters in government buildings, jails, and in shelters for victims of domestic violence.

Letting men compete in women’s sports is unfair. It reverses 50 years of advancements for women, and in some cases it can even be dangerous. We appreciate our policymakers who work hard to protect fairness in women’s sports in Arkansas and across the country.

Articles appearing on this website are written with the aid of Family Council’s researchers and writers.